Contacto
Como comprar
Entrega
Guia de compras
Inglês
333 b
Política de devolução de 30 dias
Os clientes também compraram
/
Capa mole
8.10
€
Gemcitabine was synthesised in the 1980s at Lilly Research Laboratories (Eli Lilly and Co., Indianapolis, IN). It was initially developed as an antiviral agent, but it had an extremely narrow therapeutic index due to its cytotoxicity against the parental cell lines. As it presented wide activity against various solid tumors it was then evaluated as an anticancer drug. This pyrimidine antimetabolite was firstly approved in 1996 by the Food and Drug Administration (FDA) for the treatment of pancreatic cancer. It is currently used for the treatment of many other malignancies such as lung cancer, breast cancer, lymphoma, bladder cancer, mesothelioma and ovarian cancer. This book discusses the molecular pharmacology, and the pharmacogenetics of gemcitabine. It also discusses the antineoplastic mechanism of gemcitabine on tumour cells; the systemic adverse effects; and provides detail on the clinical uses gemcitabine has on breast cancer.
Sobre o livro
Inglês
Ofereça este livro hoje
É fácil
1 Adicione ao carrinho e escolha Entregar como presente ao finalizar a compra 2 Receberá um vale 3 O livro chegará ao endereço do destinatárioTambém pode estar interessado em
/
Capa mole
14.28
€
/
Capa mole
24.82
€
/
Capa mole
4.75
€
/
Capa mole
74.99
€
/
Capa mole
11.04
€
Olá! Sou o Libroamiko, o seu conselheiro de livros.
Como posso ajudar?